47045-MOZ-C-CCS-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Reinforcing the National HIV and TB Response in Mozambique - Mozambique (01-Jan-2018-31-Dec-2020)</narrative> Mozambique, TB/HIV, Centro de Colaboração em Saúde Goals: Reduce new HIV infections 40% by 2020 (from 83,013 in 2016); Reduce HIV-related deaths (including those from TB patients) 40% by 2020 (from 62,059 in 2016); Reduce the estimated percentage of child HIV infections from HIV-positive women delivering in the past 12 months from 11.1% in 2016 to less than 5% in 2020; Reduce the incidence of TB; Reduce TB-related deaths. Objectives: Increase 36 month retention in ART from 49% in 2016 to 70% in 2020; Increase case notification rate of all forms of TB (per 100,000 population) from 278 in 2016 to 352 in 2020; Improve treatment success rate of all forms of TB from 88% in 2016 to 90% in 2020; Improve treatment success rate of RR TB and/or MDR-TB from 47% in 2016 to 60% in 2020; Build Resilient and Sustainable Systems for Health that can support efficient, scale up, quality and retention. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde Centro de Colaboração em Saúde The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Maxim Berdnikov Fund Portfolio Manager +41 58 791 1700 maxim.berdnikov@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Mozambique HIV Multicomponent, RSSH Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Reducing human rights-related barriers to HIV/TB services -> HIV and HIV/TB-related legal services HIV -> Reducing human rights-related barriers to HIV/TB services -> Improving laws, regulations and policies relating to HIV and HIV/TB HIV -> Reducing human rights-related barriers to HIV/TB services -> Legal literacy ("Know Your Rights" campaign) HIV -> Reducing human rights-related barriers to HIV/TB services -> Other intervention(s) to reduce human rights-related barriers to HIV services HIV -> Reducing human rights-related barriers to HIV/TB services -> Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity HIV -> Reducing human rights-related barriers to HIV/TB services -> Stigma and discrimination reduction (HIV/TB) HIV -> Treatment, care and support -> Treatment adherence Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Other health information systems and M&E intervention(s) Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention) 4738338.85 11673567.54 13960938.79 12791912.81 Global Fund commitment to MOZ-C-CCSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 1741128.00 Global Fund disbursement to MOZ-C-CCSP01 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 2785190.00 Global Fund disbursement to MOZ-C-CCSP01 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 1601058.17 Global Fund disbursement to MOZ-C-CCSP01 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 2810958.00 Global Fund disbursement to MOZ-C-CCSP01 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 13706605.15 Global Fund commitment to MOZ-C-CCSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde -3853578.64 Global Fund commitment to MOZ-C-CCSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 4092659.00 Global Fund disbursement to MOZ-C-CCSP01 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 3785536.00 Global Fund disbursement to MOZ-C-CCSP01 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 5542072.09 Global Fund disbursement to MOZ-C-CCSP01 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 7936512.15 Global Fund commitment to MOZ-C-CCSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde -286338.06 Global Fund commitment to MOZ-C-CCSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 6136225.00 Global Fund disbursement to MOZ-C-CCSP01 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 1800287.15 Global Fund disbursement to MOZ-C-CCSP01 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 546742.36 Funds returned to the Global Fund from MOZ-C-CCSP01 (Other Local Organizations). Centro de Colaboração em Saúde The Global Fund to Fight AIDS, Tuberculosis and Malaria -546742.36 Global Fund commitment to MOZ-C-CCSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 178452.00 Funds returned to the Global Fund from MOZ-C-CCSP01 (Other Local Organizations). Centro de Colaboração em Saúde The Global Fund to Fight AIDS, Tuberculosis and Malaria -178452.00 Global Fund commitment to MOZ-C-CCSP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 4738339.43 Expenditure reported by Centro de Colaboração em Saúde for MOZ-C-CCSP01, Jan 2018 to Dec 2018. Centro de Colaboração em Saúde 11919032.00 Expenditure reported by Centro de Colaboração em Saúde for MOZ-C-CCSP01, Jan 2019 to Dec 2019. Centro de Colaboração em Saúde 12736247.00 Expenditure reported by Centro de Colaboração em Saúde for MOZ-C-CCSP01, Jan 2020 to Dec 2020. Centro de Colaboração em Saúde -1715914.65 Expenditure reported by Centro de Colaboração em Saúde for MOZ-C-CCSP01, Jan 2021 to Jun 2021. Centro de Colaboração em Saúde <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 471. Numerator: 326. Numerator: 326. Numerator: 326. Numerator: 326. Numerator: 23. Numerator: 23. Numerator: 23. Numerator: 23. Numerator: 133. Numerator: 133. Numerator: 133. Numerator: 133. Numerator: 202. Numerator: 202. Numerator: 202. Numerator: 202. Numerator: 370. Numerator: 227. Numerator: 222. Numerator: 5. Numerator: 98. Numerator: 138. Numerator: 371. Numerator: 281. Numerator: 264; Denominator: 281; Percentage: 94%. Numerator: 17; Denominator: 281; Percentage: 6%. Numerator: 123; Denominator: 281; Percentage: 43.8%. Numerator: 158; Denominator: 281; Percentage: 56.2%. Numerator: 494. Numerator: 247. Numerator: 495. Numerator: 313. Numerator: 300; Denominator: 313; Percentage: 95.8%. Numerator: 13; Denominator: 313; Percentage: 4.2%. Numerator: 149; Denominator: 313; Percentage: 47.6%. Numerator: 164; Denominator: 313; Percentage: 52.4%. Numerator: 633. Numerator: 309. Numerator: 634. Numerator: 220. Numerator: 202; Denominator: 220; Percentage: 91.8%. Numerator: 18; Denominator: 220; Percentage: 8.2%. Numerator: 84; Denominator: 220; Percentage: 38.2%. Numerator: 136; Denominator: 220; Percentage: 61.8%. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. <narrative>Number of children <5 in contact with TB patients who began isonizide preventive therapy</narrative> Module: TB care and prevention. <narrative>Number of children <5 in contact with TB patients who began isonizide preventive therapy</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative> Module: TB care and prevention. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 3410; Denominator: 29841. Numerator: 2617; Denominator: 20938. Numerator: 1390; Denominator: 14843. Numerator: 7852; Denominator: 20938. Numerator: 1175; Denominator: 15043. Numerator: 7219; Denominator: 24064. Numerator: 6736; Denominator: 17439. Numerator: 7219; Denominator: 24064. Numerator: 7975; Denominator: 19190. Numerator: 9471; Denominator: 27059. Numerator: 7313; Denominator: 16740. Numerator: 9471; Denominator: 27059. Numerator: 9282; Denominator: 17991. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 29841. Numerator: 24369. Numerator: 24369. Numerator: 24369. Numerator: 24369. Numerator: 24369. Numerator: 6511. Numerator: 6511. Numerator: 6511. Numerator: 6511. Numerator: 6511. Numerator: 13399. Numerator: 13399. Numerator: 13399. Numerator: 13399. Numerator: 13399. Numerator: 17481. Numerator: 17481. Numerator: 17481. Numerator: 17481. Numerator: 17481. Numerator: 14816. Numerator: 14816. Numerator: 14816. Numerator: 14816. Numerator: 14816. Numerator: 13279. Numerator: 13279. Numerator: 13279. Numerator: 13279. Numerator: 13279. Numerator: 20938. Numerator: 14627. Numerator: 12846. Numerator: 1785. Numerator: 6841. Numerator: 7713. Numerator: 9366. Numerator: 5959. Numerator: 20938. Numerator: 14832. Numerator: 13194; Denominator: 15043; Percentage: 87.7%. Numerator: 1849; Denominator: 15043; Percentage: 12.3%. Numerator: 6878; Denominator: 15043; Percentage: 45.7%. Numerator: 8165; Denominator: 15043; Percentage: 54.3%. Numerator: 8171; Denominator: 15043; Percentage: 54.3%. Numerator: 6283; Denominator: 15043; Percentage: 41.8%. Numerator: 24064. Numerator: 17439. Numerator: 24064. Numerator: 18974. Numerator: 16639; Denominator: 19190; Percentage: 86.7%. Numerator: 2140; Denominator: 19190; Percentage: 11.2%. Numerator: 8811; Denominator: 19190; Percentage: 45.9%. Numerator: 9968; Denominator: 19190; Percentage: 51.9%. Numerator: 11825; Denominator: 19190; Percentage: 61.6%. Numerator: 6717; Denominator: 19190; Percentage: 35%. Numerator: 27059. Numerator: 16524. Numerator: 14743; Denominator: 16740; Percentage: 88.1%. Numerator: 1997; Denominator: 16740; Percentage: 11.9%. Numerator: 7719; Denominator: 16740; Percentage: 46.1%. Numerator: 9021; Denominator: 16740; Percentage: 53.9%. Numerator: 11191; Denominator: 16740; Percentage: 66.9%. Numerator: 5507; Denominator: 16740; Percentage: 32.9%. Numerator: 27059. Numerator: 17465. Numerator: 15958; Denominator: 17656; Percentage: 90.4%. Numerator: 1698; Denominator: 17656; Percentage: 9.6%. Numerator: 8349; Denominator: 17656; Percentage: 47.3%. Numerator: 9307; Denominator: 17656; Percentage: 52.7%. Numerator: 12639; Denominator: 17656; Percentage: 71.6%. Numerator: 5122; Denominator: 17656; Percentage: 29%. <narrative>TCP-Other(1) Number of contacts of Sputum and Genexpert positive TB patients who are evaluated for infection and disease</narrative> Module: TB care and prevention. <narrative>TCP-Other(1) Number of contacts of Sputum and Genexpert positive TB patients who are evaluated for infection and disease</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 22682; Denominator: 26519. Numerator: 15211; Denominator: 16901. Numerator: 12083; Denominator: 13621. Numerator: 15211; Denominator: 16901. Numerator: 11968; Denominator: 13819. Numerator: 17976.6; Denominator: 19974. Numerator: 11927; Denominator: 13960. Numerator: 17977.5; Denominator: 19975. Numerator: 13244; Denominator: 14991. Numerator: 20660.4; Denominator: 22956. Numerator: 15182; Denominator: 16917. Numerator: 20661.3; Denominator: 22957. Numerator: 16428; Denominator: 18048. <narrative>TCS-Other (1): Number of patiets in need reached through community health network (patients on ART lost to follow-up) that are not reached through the health facility defaulter tracing mechanism</narrative> Module: Treatment, care and support. <narrative>TCS-Other (1): Number of patiets in need reached through community health network (patients on ART lost to follow-up) that are not reached through the health facility defaulter tracing mechanism</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Percentage: 53.5%. Numerator: 34427. Numerator: 0; Percentage: 0%. Numerator: 34427. Numerator: 73. Numerator: 37504. Numerator: 20935. Numerator: 37504. Numerator: 38127. Numerator: 40204. Numerator: 42713; Percentage: 106%. Numerator: 40204. Numerator: 49597. 47045-MOZ-C-CCS-2 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Reinforcing the National HIV and TB Response in Mozambique - Mozambique (01-Jan-2021-31-Dec-2023)</narrative> Mozambique, TB/HIV, Centro de Colaboração em Saúde Goals: Reduce new HIV infections 25% by 2025; Reduce HIV-related deaths 30% by 2025; Reduce the estimated percentage of child HIV infections from HIV-positive women delivering in the past 12 months to <5% by 2025; Reduction in the incidence of tuberculosis from 361/100,000 people in 2019 to 265/100,000 in 2025 (average reduction of 5% per year); Reduce TB-related mortality (per 100,000 population) by 39% até 2023. Objectives: Increase the percentage of PLHIV who know their status to 95% by 2025; Increase coverage of PLHIV on ART to 81% by 2025; Increase viral supression among PLHIV to 73% by 2025; Increase case notification rate of all forms of TB (per 100,000 population) from 340 in 2019 to 402 in 2023; Sustain treatment success rate of all forms of TB in 90% or above; Improve treatment success rate of RR TB and/or MDR-TB from 57% in 2019 to 70% in 2023. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde Centro de Colaboração em Saúde The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Maxim Berdnikov Fund Portfolio Manager +41 58 791 1700 maxim.berdnikov@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Mozambique HIV Multicomponent, RSSH Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> PMTCT -> Prong 4: Treatment, care and support to mothers living with HIV, their children and families HIV -> Reducing human rights-related barriers to HIV/TB services -> HIV and HIV/TB-related legal services HIV -> Reducing human rights-related barriers to HIV/TB services -> Legal literacy ("Know Your Rights" campaign) HIV -> Reducing human rights-related barriers to HIV/TB services -> Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity HIV -> Reducing human rights-related barriers to HIV/TB services -> Stigma and discrimination reduction (HIV/TB) HIV -> Treatment, care and support -> Differentiated ART service delivery and HIV care Multicomponent -> Program management -> Grant management RSSH -> RSSH: Community systems strengthening -> Institutional capacity building, planning and leadership development RSSH -> RSSH: Financial management systems -> Routine grant financial management RSSH -> RSSH: Health management information systems and M&E -> Civil registration and vital statistics RSSH -> RSSH: Health management information systems and M&E -> Program and data quality Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB) Tuberculosis -> MDR-TB -> Community MDR-TB care delivery Tuberculosis -> MDR-TB -> Treatment (MDR-TB) Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention) Tuberculosis -> TB care and prevention -> Community TB care delivery Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) 17884547.76 24365867.93 23017191.16 2874874.32 1490115.74 32066756.20 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 6027559.20 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 6557917.20 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 7894560.00 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 1721630.44 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 2558163.62 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 4958267.47 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 10714610.45 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde -2348658.27 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 296760.12 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 10417850.33 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 13196318.93 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 567720.02 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 334780.48 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 5317159.59 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 4698378.68 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 835621.85 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde -1442658.31 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 11548293.60 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 4929645.03 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 676308.60 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 685450.59 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 4459592.02 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 591200.00 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 1640631.35 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde -206097.36 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 727286.68 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 461281.70 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 211688.00 Funds returned to the Global Fund from MOZ-C-CCSP02 (Other Local Organizations). Centro de Colaboração em Saúde The Global Fund to Fight AIDS, Tuberculosis and Malaria -211688.00 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde -452062.97 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 1097355.00 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 1097355.00 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 1925892.53 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 752080.40 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 968538.23 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde -709133.00 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 709133.00 Funds returned to the Global Fund from MOZ-C-CCSP02 (Other 3rd Party). Centro de Colaboração em Saúde The Global Fund to Fight AIDS, Tuberculosis and Malaria 193562.90 Global Fund disbursement to MOZ-C-CCSP02 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 274897.00 Funds returned to the Global Fund from MOZ-C-CCSP02 (Other Local Organizations). Centro de Colaboração em Saúde The Global Fund to Fight AIDS, Tuberculosis and Malaria -274897.00 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 206277.78 Funds returned to the Global Fund from MOZ-C-CCSP02 (Other Local Organizations). Centro de Colaboração em Saúde The Global Fund to Fight AIDS, Tuberculosis and Malaria -206277.78 Global Fund commitment to MOZ-C-CCSP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 17672859.00 Expenditure reported by Centro de Colaboração em Saúde for MOZ-C-CCSP02, Jan 2021 to Dec 2021. Centro de Colaboração em Saúde 23298122.00 Expenditure reported by Centro de Colaboração em Saúde for MOZ-C-CCSP02, Jan 2022 to Dec 2022. Centro de Colaboração em Saúde 22717138.00 Expenditure reported by Centro de Colaboração em Saúde for MOZ-C-CCSP02, Jan 2023 to Dec 2023. Centro de Colaboração em Saúde 1218257.55 Expenditure reported by Centro de Colaboração em Saúde for MOZ-C-CCSP02, Jan 2024 to Jun 2024. Centro de Colaboração em Saúde 1381092.85 Expenditure reported by Centro de Colaboração em Saúde for MOZ-C-CCSP02, Jul 2024 to Dec 2024. Centro de Colaboração em Saúde 1084876.67 Expenditure reported by Centro de Colaboração em Saúde for MOZ-C-CCSP02, Jan 2025 to Jun 2025. Centro de Colaboração em Saúde 1978409.05 Expenditure reported by Centro de Colaboração em Saúde for MOZ-C-CCSP02, Jan 2025 to Dec 2025. Centro de Colaboração em Saúde <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2020 - Funding Request - Window 2b - TB/HIV - Mozambique - English</narrative> Funding Request of funding request FR817-MOZ-C. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 727. Numerator: 674. Numerator: 674. Numerator: 674. Numerator: 674. Numerator: 674. Numerator: 674. Numerator: 53. Numerator: 53. Numerator: 53. Numerator: 53. Numerator: 53. Numerator: 53. Numerator: 294. Numerator: 294. Numerator: 294. Numerator: 294. Numerator: 294. Numerator: 294. Numerator: 433. Numerator: 433. Numerator: 433. Numerator: 433. Numerator: 433. Numerator: 433. Numerator: 378.37. Numerator: 226. Numerator: 146; Denominator: 226; Percentage: 64.6%. Numerator: 80; Denominator: 226; Percentage: 35.4%. Numerator: 14; Denominator: 226; Percentage: 6.2%. Numerator: 212; Denominator: 226; Percentage: 93.8%. Numerator: 899.4. Numerator: 559. Numerator: 521. Numerator: 333. Numerator: 198; Denominator: 333; Percentage: 59.46%. Numerator: 135; Denominator: 333; Percentage: 40.54%. Numerator: 20; Denominator: 333; Percentage: 6.01%. Numerator: 313; Denominator: 333; Percentage: 93.99%. Numerator: 912. Numerator: 765. Numerator: 456. Numerator: 357. Numerator: 219; Denominator: 357; Percentage: 61.34%. Numerator: 138; Denominator: 357; Percentage: 38.66%. Numerator: 18; Denominator: 357; Percentage: 5.04%. Numerator: 339; Denominator: 357; Percentage: 94.96%. Numerator: 456. Numerator: 408. Numerator: 378; Denominator: 408; Percentage: 92.65%. Numerator: 30; Denominator: 408; Percentage: 7.35%. Numerator: 153; Denominator: 408; Percentage: 37.5%. Numerator: 255; Denominator: 408; Percentage: 62.5%. Numerator: 501. Numerator: 448. Numerator: 411; Denominator: 448; Percentage: 91.74%. Numerator: 37; Denominator: 448; Percentage: 8.26%. Numerator: 212; Denominator: 448; Percentage: 47.32%. Numerator: 236; Denominator: 448; Percentage: 52.68%. Numerator: 1002. Numerator: 865. Numerator: 501. Numerator: 417. Numerator: 389; Denominator: 417; Percentage: 93.29%. Numerator: 28; Denominator: 417; Percentage: 6.71%. Numerator: 179; Denominator: 417; Percentage: 42.93%. Numerator: 238; Denominator: 417; Percentage: 57.07%. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Percentage of confirmed RR/MDR-TB cases tested for resistance to second-line drugs</narrative> Module: MDR-TB. <narrative>Percentage of confirmed RR/MDR-TB cases tested for resistance to second-line drugs</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 675.38; Denominator: 711. Numerator: 526; Denominator: 553. Numerator: 189; Denominator: 523. Numerator: 526; Denominator: 553. Numerator: 189; Denominator: 226. Numerator: 0; Denominator: 297. Denominator: 294. <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative> Module: PMTCT. <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 22597; Denominator: 37766. Numerator: 24586; Denominator: 39654. Numerator: 25669; Denominator: 30258. Numerator: 12293; Denominator: 19827. Numerator: 13349; Denominator: 15625. Numerator: 12293; Denominator: 19827. Numerator: 12320; Denominator: 14633. Numerator: 13949; Denominator: 20819. Numerator: 13498; Denominator: 15598. Numerator: 27898; Denominator: 41638. Numerator: 25923; Denominator: 30039. Numerator: 13949; Denominator: 20819. Numerator: 12425; Denominator: 14441. Numerator: 16395; Denominator: 21859.5. Numerator: 14534; Denominator: 16559. Numerator: 32790; Denominator: 43719. Numerator: 28499; Denominator: 32403. Numerator: 16395; Denominator: 21859.5. Numerator: 13965; Denominator: 15844. <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative> Module: PMTCT. <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special. Numerator: 29455; Denominator: 37766. Numerator: 16853; Denominator: 39654. Numerator: 19449; Denominator: 39654. Numerator: 33706; Denominator: 39654. Numerator: 37664; Denominator: 32876. Numerator: 16853; Denominator: 39654. Numerator: 18215; Denominator: 32876. Numerator: 18737; Denominator: 41638. Numerator: 18484; Denominator: 41638. Numerator: 37474; Denominator: 41638. Numerator: 35768; Denominator: 17457. Numerator: 18737; Denominator: 41638. Numerator: 17284; Denominator: 17457. Numerator: 20767; Denominator: 43720. Numerator: 17390; Denominator: 43720. Numerator: 41534; Denominator: 43720. Numerator: 35162; Denominator: 43720. Numerator: 20767; Denominator: 43720. Numerator: 17772; Denominator: 43720. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative> Module: TB care and prevention. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 42383. Numerator: 38008. Numerator: 38008. Numerator: 38008. Numerator: 38008. Numerator: 38008. Numerator: 38008. Numerator: 4375. Numerator: 4375. Numerator: 4375. Numerator: 4375. Numerator: 4375. Numerator: 4375. Numerator: 7615. Numerator: 7615. Numerator: 7615. Numerator: 7615. Numerator: 7615. Numerator: 7615. Numerator: 22344. Numerator: 22344. Numerator: 22344. Numerator: 22344. Numerator: 22344. Numerator: 22344. Numerator: 20039. Numerator: 20039. Numerator: 20039. Numerator: 20039. Numerator: 20039. Numerator: 20039. Numerator: 35875. Numerator: 35875. Numerator: 35875. Numerator: 35875. Numerator: 35875. Numerator: 35875. Numerator: 6508. Numerator: 6508. Numerator: 6508. Numerator: 6508. Numerator: 6508. Numerator: 6508. Numerator: 21901.37. Numerator: 16152. Numerator: 10725; Denominator: 16342; Percentage: 65.6%. Numerator: 77; Denominator: 16342; Percentage: 0.5%. Numerator: 5249; Denominator: 15316; Percentage: 34.3%. Numerator: 7348; Denominator: 16342; Percentage: 45%. Numerator: 5540; Denominator: 16342; Percentage: 33.9%. Numerator: 13301; Denominator: 16152; Percentage: 82.3%. Numerator: 8960; Denominator: 16342; Percentage: 54.8%. Numerator: 52453.4. Numerator: 37173. Numerator: 30552. Numerator: 21021. Numerator: 13483; Denominator: 21218; Percentage: 63.55%. Numerator: 1252; Denominator: 21218; Percentage: 5.9%. Numerator: 8458; Denominator: 20224; Percentage: 41.82%. Numerator: 9873; Denominator: 21218; Percentage: 46.53%. Numerator: 6483; Denominator: 21218; Percentage: 30.55%. Numerator: 18823; Denominator: 21021; Percentage: 89.54%. Numerator: 11345; Denominator: 21218; Percentage: 53.47%. Numerator: 26008. Numerator: 24164. Numerator: 16439; Denominator: 24357; Percentage: 67.49%. Numerator: 46; Denominator: 24357; Percentage: 0.19%. Numerator: 10144; Denominator: 23157; Percentage: 43.81%. Numerator: 11559; Denominator: 24357; Percentage: 47.46%. Numerator: 7872; Denominator: 24357; Percentage: 32.32%. Numerator: 21661; Denominator: 24164; Percentage: 89.64%. Numerator: 12798; Denominator: 24357; Percentage: 52.54%. Numerator: 52016. Numerator: 48668. Numerator: 26008. Numerator: 24504. Numerator: 22043; Denominator: 24504; Percentage: 89.96%. Numerator: 2600; Denominator: 24504; Percentage: 10.61%. Numerator: 11482; Denominator: 24504; Percentage: 46.86%. Numerator: 11791; Denominator: 24660; Percentage: 47.81%. Numerator: 12869; Denominator: 24660; Percentage: 52.19%. Numerator: 17024; Denominator: 24504; Percentage: 69.47%. Numerator: 7480; Denominator: 24504; Percentage: 30.53%. Numerator: 26816. Numerator: 24495. Numerator: 22012; Denominator: 24495; Percentage: 89.86%. Numerator: 2483; Denominator: 24495; Percentage: 10.14%. Numerator: 12047; Denominator: 24495; Percentage: 49.18%. Numerator: 11621; Denominator: 24495; Percentage: 47.44%. Numerator: 13025; Denominator: 24495; Percentage: 53.17%. Numerator: 17482; Denominator: 24495; Percentage: 71.37%. Numerator: 7013; Denominator: 24495; Percentage: 28.63%. Numerator: 53632. Numerator: 50787. Numerator: 26816. Numerator: 26292. Numerator: 23644; Denominator: 26292; Percentage: 89.93%. Numerator: 2648; Denominator: 26292; Percentage: 10.07%. Numerator: 13143; Denominator: 26292; Percentage: 49.99%. Numerator: 12648; Denominator: 26292; Percentage: 48.11%. Numerator: 13781; Denominator: 26292; Percentage: 52.42%. Numerator: 19108; Denominator: 26292; Percentage: 72.68%. Numerator: 7184; Denominator: 26292; Percentage: 27.32%. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Module: TB care and prevention. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 6440; Denominator: 6879. Numerator: 6157; Denominator: 6577. Numerator: 6157; Denominator: 6577. Numerator: 6157; Denominator: 6577. Numerator: 6157; Denominator: 6577. Numerator: 6157; Denominator: 6577. Numerator: 6157; Denominator: 6577. Numerator: 9084; Denominator: 9463. Numerator: 11359; Denominator: 12023. Numerator: 9084; Denominator: 9463. Numerator: 5235; Denominator: 5540. Numerator: 4977; Denominator: 5275. Numerator: 6124; Denominator: 6483. Numerator: 5783; Denominator: 6146. Numerator: 14939; Denominator: 15358. Numerator: 7605; Denominator: 7872. Numerator: 7169; Denominator: 7431. Numerator: 7334; Denominator: 7486. Numerator: 6965; Denominator: 7106. Numerator: 6894; Denominator: 7013. Numerator: 6588; Denominator: 6702. Numerator: 13895; Denominator: 14197. Numerator: 7001; Denominator: 7184. Numerator: 6678; Denominator: 6837. <narrative>TCS-Other: Number of patients in need reached through community health networks (patients lost to follow up) that are not reached through the health facility defaulter tracing mechanism</narrative> Module: Treatment, care and support. <narrative>TCS-Other: Number of patients in need reached through community health networks (patients lost to follow up) that are not reached through the health facility defaulter tracing mechanism</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. 47045-MOZ-C-CCS-3 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Reinforcing the National HIV and TB Response in Mozambique - Mozambique (01-Jan-2024-31-Dec-2026)</narrative> Mozambique, TB/HIV, Centro de Colaboração em Saúde Goals: Reduce new HIV infections 25% by 2025; Reduce HIV-related deaths 30% by 2025; Reduce the estimated percentage of child HIV infections from HIV-positive women delivering in the past 12 months to <5% by 2025; Reduce the incidence of TB (per 100,000 population) from 361 in 2022 to 310 in 2026; Reduce TB-related Mortality (per 100,000 population) from 43 in 2022 to 35 in 2026. Objectives: Increase coverage of PLHIV on ART to 90% by 2025; Increase viral supression among PLHIV to 86% by 2025; Identify 90% of incident TB cases and offer appropriate treatment to all them; Identfy 90% of incident TB cases in vulnerable population, offer appropriate treatment to all of them to successfully treat 90% of them; Identify all incident cases of resistant tuberculosis offer appropriate treatment; Successfully treat 90% or more of all drug-sensitive tuberculosis patients regardless of their HIV status. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde Centro de Colaboração em Saúde The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Maxim Berdnikov Fund Portfolio Manager +41 58 791 1700 maxim.berdnikov@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Mozambique HIV Multicomponent, RSSH Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Prevention of incident HIV among pregnant and breastfeeding women HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Retention support for pregnant and breastfeeding women (facility and community) HIV -> Reducing human rights-related barriers to HIV/TB services -> Eliminating stigma and discrimination in all settings HIV -> Reducing human rights-related barriers to HIV/TB services -> Increasing access to justice (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> Legal literacy ("Know Your Rights") (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity HIV -> Treatment, care and support -> Diagnosis and management of advanced HIV disease (adults and children) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15) HIV -> Treatment, care and support -> Integrated management of common co-infections and co-morbidities (adults and children) Multicomponent -> Program management -> Grant management RSSH -> RSSH: Community systems strengthening -> Capacity building and leadership development RSSH -> RSSH: Community systems strengthening -> Community engagement, linkages and coordination RSSH -> RSSH: Community systems strengthening -> Community-led monitoring RSSH -> RSSH: Community systems strengthening -> Community-led research and advocacy RSSH -> RSSH: Monitoring and evaluation systems -> Data quality Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis Tuberculosis -> TB diagnosis, treatment and care -> TB treatment, care and support 24694411.80 22668373.79 22101210.44 40948863.59 Global Fund commitment to MOZ-C-CCSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 7302165.00 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 5386142.32 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 7095740.30 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 6335736.80 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 6114150.53 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 5872672.26 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 709133.00 Global Fund commitment to MOZ-C-CCSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 709133.00 Global Fund disbursement to MOZ-C-CCSP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde -2842256.38 Global Fund commitment to MOZ-C-CCSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 8147273.00 Global Fund commitment to MOZ-C-CCSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 3552789.00 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 4594484.00 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 11277490.84 Global Fund commitment to MOZ-C-CCSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 1541152.20 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 2917779.62 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 6814271.00 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 8828007.38 Global Fund commitment to MOZ-C-CCSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde -4288.02 Global Fund commitment to MOZ-C-CCSP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 5778199.82 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 458847.80 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 2590959.76 Global Fund disbursement to MOZ-C-CCSP03 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Centro de Colaboração em Saúde 24694411.83 Expenditure reported by Centro de Colaboração em Saúde for MOZ-C-CCSP03, Jan 2024 to Dec 2024. Centro de Colaboração em Saúde 21436100.94 Expenditure reported by Centro de Colaboração em Saúde for MOZ-C-CCSP03, Jan 2025 to Dec 2025. Centro de Colaboração em Saúde <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2023 - Funding Request - Window 2 - TB/HIV - Mozambique - English</narrative> Funding Request of funding request FR1527-MOZ-C. 1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons. 2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation. 3 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of USD 77,209,168 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction with the Host Country’s compliance with the requirements listed at 5.3(1)(a) and 5.3(1)(b) below (“Co-Financing Requirements”). The Grantee acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: (a) progressively increase government expenditure on health to meet national universal health coverage goals; and (b) maintain domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee acknowledges and agrees that the Host Country shall, as set out in the Commitment Letter ‘Compromisso do Governo de Cofinanciamento das Respostas Nacionais Apoiadas pelo Fundo Global’, dated 29 November 2023 (the “Commitment Letter”), unless otherwise agreed in writing with the Global Fund: (a) fulfil a total minimum co-financing commitment of USD194.5 million of investments in RSSH from 2024 to 2026 (inclusive); and (b) provide to the Global Fund, by no later than August 15 of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including: i. the approved Economic and Social Plan Law (‘Lei do Plano Económico'), and the State Budget (‘Orçamento do Estado’) for the current fiscal year; ii. the State General Account (‘Conta Geral do Estado’) for the previous fiscal year; iii. the latest Projections of the Medium-Term Fiscal Scenario (‘Projecções do Cenário Fiscal de Médio Prazo'); and iv. the domestic government expenditures incurred in the previous fiscal year and the amounts budgeted for the current fiscal year, for the following categories of human resources for health: (1) Maternal and Child Health Nurse; (2) Laboratory Technician; and (3) General Medicine Technician. 4 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement. 6 - The Global Fund may disburse Grant Funds in a currency other than that specified in the Grant Confirmation. In such cases, the exchange rate used to calculate the amount of the disbursement into its equivalent in the currency specified in the Grant Confirmation shall be the relevant exchange rate reflected in the Program budget. <narrative>Percentage of people newly diagnosed with HIV initiated on ART</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of people newly diagnosed with HIV initiated on ART</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 17835.04; Denominator: 22576. Numerator: 502; Denominator: 703. Numerator: 28; Denominator: 29. Numerator: 10950; Denominator: 11031. Numerator: 6102; Denominator: 6162. Numerator: 13793; Denominator: 13855. Numerator: 7171; Denominator: 7202. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 710; Denominator: 759. Numerator: 817; Denominator: 853. Numerator: 497; Denominator: 524. Numerator: 1122; Denominator: 1162. Numerator: 595; Denominator: 613. <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 530; Denominator: 732. Numerator: 582; Denominator: 766. Numerator: 333; Denominator: 433. Numerator: 677; Denominator: 857. Numerator: 324; Denominator: 400. <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative> Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B. <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special. Numerator: 61450; Denominator: 84994; Percentage: 72.3%. Numerator: 83242; Denominator: 84994; Percentage: 97.94%. Numerator: 83242; Denominator: 84994; Percentage: 97.94%. Numerator: 1752; Denominator: 84994; Percentage: 2.06%. Numerator: 1752; Denominator: 84994; Percentage: 2.06%. Numerator: 0; Denominator: 84994; Percentage: 0%. Numerator: 0; Denominator: 84994; Percentage: 0%. Percentage: 42.5%. Percentage: 42.5%. Numerator: 5115; Denominator: 8799; Percentage: 58.13%. Percentage: 42.5%. Numerator: 2519; Denominator: 8799; Percentage: 28.63%. Numerator: 4941. Numerator: 150. Numerator: 24. Percentage: 43.5%. Percentage: 87%. Numerator: 6752; Denominator: 9695; Percentage: 69.64%. Percentage: 87%. Numerator: 3588; Denominator: 9695; Percentage: 37.01%. Numerator: 6689. Numerator: 63. Percentage: 45%. Percentage: 45%. <narrative>Number of community organizations that received a pre-defined package of training</narrative> Module: RSSH: Community systems strengthening. <narrative>Number of community organizations that received a pre-defined package of training</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 45. Numerator: 45; Denominator: 45; Percentage: 100%. Numerator: 0; Denominator: 45; Percentage: 0%. Numerator: 0; Denominator: 45; Percentage: 0%. Numerator: 0; Denominator: 45; Percentage: 0%. Numerator: 9; Denominator: 45; Percentage: 20%. Numerator: 20. Numerator: 45. Numerator: 49. Numerator: 25. Numerator: 25. Numerator: 49; Denominator: 49; Percentage: 100%. Numerator: 0; Denominator: 49. Numerator: 0; Denominator: 49. Numerator: 0; Denominator: 49. Numerator: 0; Denominator: 49. <narrative>Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received</narrative> Module: RSSH: Monitoring and evaluation systems. <narrative>Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 20770; Denominator: 22950. Numerator: 32486; Denominator: 32992. Numerator: 18010; Denominator: 18264. Numerator: 36857; Denominator: 37526. Numerator: 18631; Denominator: 18776. <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative> Module: RSSH: Monitoring and evaluation systems. <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 19872; Denominator: 22950. Numerator: 31217; Denominator: 32992. Numerator: 17091; Denominator: 18516. Numerator: 35600; Denominator: 36857. Numerator: 18175; Denominator: 18631. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 48436.96. Numerator: 43751; Denominator: 48905; Percentage: 89.46%. Numerator: 43751; Denominator: 48905; Percentage: 89.46%. Numerator: 5154; Denominator: 48905; Percentage: 10.54%. Numerator: 5154; Denominator: 48905; Percentage: 10.54%. Numerator: 21623; Denominator: 48905; Percentage: 44.21%. Numerator: 21623; Denominator: 48905; Percentage: 44.21%. Numerator: 23292; Denominator: 48905; Percentage: 47.63%. Numerator: 23292; Denominator: 48905; Percentage: 47.63%. Numerator: 25613; Denominator: 48905; Percentage: 52.37%. Numerator: 25613; Denominator: 48905; Percentage: 52.37%. Numerator: 33643; Denominator: 48905; Percentage: 68.79%. Numerator: 33643; Denominator: 48905; Percentage: 68.79%. Numerator: 15262; Denominator: 48905; Percentage: 31.21%. Numerator: 15262; Denominator: 48905; Percentage: 31.21%. Numerator: 0; Denominator: 48905; Percentage: 0%. Numerator: 0; Denominator: 48905; Percentage: 0%. Numerator: 53566. Numerator: 49951. Numerator: 26783. Numerator: 26783. Numerator: 27852. Numerator: 42511. Numerator: 7440. Numerator: 25576. Numerator: 23435. Numerator: 26516. Numerator: 35973. Numerator: 13978. Numerator: 0. Numerator: 56246. Numerator: 58330. Numerator: 28123. Numerator: 28123. Numerator: 31667. Numerator: 52073. Numerator: 6722. Numerator: 30479. Numerator: 27599. Numerator: 31196. Numerator: 43804. Numerator: 14526. Numerator: 29528. Numerator: 29528. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 24329; Denominator: 48436.96. Numerator: 26677; Denominator: 49951. Numerator: 16818; Denominator: 27852. Numerator: 37973; Denominator: 58330. Numerator: 20409; Denominator: 31667. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 34492; Denominator: 37421; Percentage: 92.17%. Numerator: 31026; Denominator: 33804; Percentage: 91.78%. Numerator: 3466; Denominator: 3617; Percentage: 95.83%. Numerator: 10745; Denominator: 12066; Percentage: 89.05%. Numerator: 10745; Denominator: 12066; Percentage: 89.05%. Percentage: 94%. Percentage: 94%. Numerator: 45477; Denominator: 48693; Percentage: 93.4%. Percentage: 94%. Numerator: 22542; Denominator: 24226; Percentage: 93.05%. Numerator: 12789; Denominator: 14241; Percentage: 89.8%. Percentage: 94%. Numerator: 45572; Denominator: 48744; Percentage: 93.49%. Percentage: 94%. Percentage: 94%. Numerator: 25444; Denominator: 27026; Percentage: 94.15%. Numerator: 0. Numerator: 10517; Denominator: 11522; Percentage: 91.28%. Percentage: 96%. Percentage: 96%. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Module: TB/DR-TB Prevention. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 14925; Denominator: 15262. Numerator: 14117; Denominator: 14438. Numerator: 14117; Denominator: 14438. Numerator: 540; Denominator: 548. Numerator: 540; Denominator: 548. Numerator: 268; Denominator: 276. Numerator: 268; Denominator: 276. Numerator: 13772; Denominator: 13978. Numerator: 7138; Denominator: 7237. Numerator: 13129; Denominator: 13312. Numerator: 443; Denominator: 461. Numerator: 200; Denominator: 205. Numerator: 14311; Denominator: 14526. Numerator: 7518; Denominator: 7630. Numerator: 13752; Denominator: 13960. Numerator: 399; Denominator: 404. Numerator: 160; Denominator: 162. <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special. Numerator: 26855; Denominator: 144680. Numerator: 7161.66; Denominator: 162764.52. Numerator: 14323.4; Denominator: 162764.5. Numerator: 14111; Denominator: 82740. Numerator: 7161.66; Denominator: 162764.52. Numerator: 7518; Denominator: 82740. Numerator: 7448.5; Denominator: 169283.78. Numerator: 14897; Denominator: 169283.8. Numerator: 17394; Denominator: 90316. Numerator: 7448.5; Denominator: 169283.78. Numerator: 8813; Denominator: 90316. Numerator: 6217.74; Denominator: 172714.74. Numerator: 6217.74; Denominator: 172714.74. <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 16848; Denominator: 17722. Numerator: 14572; Denominator: 14587. Numerator: 7801; Denominator: 7810. Numerator: 17898; Denominator: 17887. Numerator: 9076; Denominator: 9059. <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative> Module: Treatment, care and support. <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 23416; Denominator: 78614. Numerator: 30833; Denominator: 74930. Numerator: 30833; Denominator: 74930. Numerator: 68025; Denominator: 81257. Numerator: 68025; Denominator: 81257. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 144680; Denominator: 177988. Numerator: 162764.5; Denominator: 182698.6. Numerator: 82740; Denominator: 118632. Numerator: 157579.03; Denominator: 182698.64. Numerator: 162764.52; Denominator: 182698.64. Numerator: 82740; Denominator: 118632. Numerator: 169283.8; Denominator: 184623.9. Numerator: 90316; Denominator: 117517. Numerator: 166024.19; Denominator: 184623.94. Numerator: 169283.78; Denominator: 184623.94. Numerator: 90316; Denominator: 117517. Numerator: 170999.3; Denominator: 186447.43. Numerator: 172714.74; Denominator: 186447.43. <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative> Module: Treatment, care and support. <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special. Numerator: 78816; Denominator: 84994. Numerator: 7654; Denominator: 8799. Numerator: 3923; Denominator: 8799. Numerator: 7986; Denominator: 9695. Numerator: 4112; Denominator: 9695. <narrative>TCS-Other: Number and proportion of patients reached and re-integrated into care through the community health networks among those not reached through the health facility client tracing mechanism (list given to community network)</narrative> Module: Treatment, care and support. <narrative>TCS-Other: Number and proportion of patients reached and re-integrated into care through the community health networks among those not reached through the health facility client tracing mechanism (list given to community network)</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 61118; Denominator: 73253. Numerator: 32086.95; Denominator: 37749. Numerator: 32087; Denominator: 37749. Numerator: 49068; Denominator: 55136. Numerator: 32086.95; Denominator: 37749. Numerator: 49068; Denominator: 55136. Numerator: 36900; Denominator: 41000. Numerator: 47987; Denominator: 49236. Numerator: 36899.99; Denominator: 40999.99. Numerator: 36899.99; Denominator: 40999.99. Numerator: 47987; Denominator: 49236. Numerator: 35142.85; Denominator: 36992.47. Numerator: 35142.85; Denominator: 36992.47.